- Home
- AMRN vs OPFI Comparison
AMRN vs OPFI Comparison
Compare AMRN & OPFI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$14.14
Company Overview
Basic Information| Metric | AMRN | OPFI |
|---|---|---|
| Founded | 1989 | 2009 |
| Country | Ireland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 339.8M | 288.7M |
| IPO Year | 1993 | N/A |
Fundamental Metrics
Financial Performance| Metric | AMRN | OPFI |
|---|---|---|
| Price | $14.14 | $11.13 |
| Analyst Decision | Strong Sell | Buy |
| Analyst Count | 1 | 1 |
| Target Price | $12.00 | ★ $13.50 |
| AVG Volume (30 Days) | 87.4K | ★ 520.3K |
| Earning Date | 10-29-2025 | 10-29-2025 |
| Dividend Yield | N/A | ★ 2.25% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.14 |
| Revenue | $226,733,000.00 | ★ $335,423,000.00 |
| Revenue This Year | N/A | $120.32 |
| Revenue Next Year | N/A | $10.85 |
| P/E Ratio | ★ N/A | $81.13 |
| Revenue Growth | N/A | ★ 28.69 |
| 52 Week Low | $7.08 | $6.81 |
| 52 Week High | $20.90 | $17.73 |
Technical Indicators
Market Signals| Indicator | AMRN | OPFI |
|---|---|---|
| Relative Strength Index (RSI) | 41.21 | 58.80 |
| Support Level | $13.50 | $10.62 |
| Resistance Level | $14.30 | $11.69 |
| Average True Range (ATR) | 0.75 | 0.45 |
| MACD | -0.00 | 0.04 |
| Stochastic Oscillator | 25.43 | 63.61 |
Price Performance
Historical Comparison AMRN
OPFI
About AMRN Amarin Corporation plc
Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa.
About OPFI OppFi Inc.
OppFi Inc is a tech-enabled, mission-driven specialty finance platform that broadens the reach of community banks to extend credit access to everyday Americans. It recognizes revenue through finance charges on installment and SalaryTap contracts based on the interest method.